These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21673683)

  • 1. Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma.
    Miyamoto M; Ojima H; Iwasaki M; Shimizu H; Kokubu A; Hiraoka N; Kosuge T; Yoshikawa D; Kono T; Furukawa H; Shibata T
    Br J Cancer; 2011 Jun; 105(1):131-8. PubMed ID: 21673683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX4 is associated with poor prognosis in cholangiocarcinoma.
    Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
    Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray.
    Nitta T; Mitsuhashi T; Hatanaka Y; Miyamoto M; Oba K; Tsuchikawa T; Suzuki Y; Hatanaka KC; Hirano S; Matsuno Y
    Br J Cancer; 2014 Sep; 111(7):1363-72. PubMed ID: 25077440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma.
    Yoshikawa D; Ojima H; Iwasaki M; Hiraoka N; Kosuge T; Kasai S; Hirohashi S; Shibata T
    Br J Cancer; 2008 Jan; 98(2):418-25. PubMed ID: 18087285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines.
    Xu L; Hausmann M; Dietmaier W; Kellermeier S; Pesch T; Stieber-Gunckel M; Lippert E; Klebl F; Rogler G
    BMC Cancer; 2010 Jun; 10():302. PubMed ID: 20565817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma.
    Zhang KJ; Zhang BY; Zhang KP; Tang LM; Liu SS; Zhu DM; Zhang DL
    World J Gastroenterol; 2010 May; 16(20):2554-7. PubMed ID: 20503457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of EGFR family gene aberrations in cholangiocarcinoma.
    Yang X; Wang W; Wang C; Wang L; Yang M; Qi M; Su H; Sun X; Liu Z; Zhang J; Qin X; Han B
    Oncol Rep; 2014 Aug; 32(2):700-8. PubMed ID: 24927194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.
    Guo S; Liu HD; Liu YF; Liu L; Sun Q; Cui XJ
    Tumour Biol; 2015 Jan; 36(1):353-64. PubMed ID: 25262276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.
    Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X
    Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of Survivin protein in extrahepatic cholangiocarcinoma and its relationship with the prognosis].
    Qin XL; Xue HZ; Wang ZR; Liu HS; Zhou HB; Ma W
    Zhonghua Wai Ke Za Zhi; 2009 Dec; 47(24):1852-6. PubMed ID: 20193400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma.
    Hirashita T; Iwashita Y; Ohta M; Komori Y; Eguchi H; Yada K; Kitano S
    J Gastrointest Surg; 2012 Apr; 16(4):842-8. PubMed ID: 22246855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma.
    Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
    Anal Cell Pathol (Amst); 2020; 2020():9831646. PubMed ID: 32850288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
    Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
    Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
    Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
    Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of nerve growth factor and tropomyosin-receptor-kinase signaling pathway in intrahepatic cholangiocarcinoma.
    Yang XQ; Xu YF; Guo S; Liu Y; Ning SL; Lu XF; Yang H; Chen YX
    World J Gastroenterol; 2014 Apr; 20(14):4076-84. PubMed ID: 24744599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulators of apoptosis in cholangiocarcinoma.
    Jhala NC; Vickers SM; Argani P; McDonald JM
    Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis.
    Terada T; Nakanuma Y; Sirica AE
    Hum Pathol; 1998 Feb; 29(2):175-80. PubMed ID: 9490278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.